{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:11:28Z","timestamp":1791983488445,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-00932"],"award-info":[{"award-number":["2017-00932"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2012-2844"],"award-info":[{"award-number":["2012-2844"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejogrb.2020.06.056","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:57:22Z","timestamp":1593187042000},"page":"330-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0862-6265","authenticated-orcid":false,"given":"Kiriaki","family":"Papaikonomou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Frisendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair R.W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-1444","authenticated-orcid":false,"given":"Kristina","family":"Gemzell-Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10057","key":"10.1016\/j.ejogrb.2020.06.056_bib0005","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(16)31333-2","article-title":"Quality maternity care for every woman, everywhere: a call to action","volume":"388","author":"Koblinsky","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.06.056_bib0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.06.056_bib0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2018.10.012","article-title":"Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study","volume":"111","author":"Bradley","year":"2019","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.06.056_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejogrb.2020.06.056_bib0025","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum. Reprod. (Oxford, England)"},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cct.2017.02.002","article-title":"Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids","volume":"55","author":"Seitz","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0035","article-title":"Progesterone receptor modulators for endometriosis","volume":"7","author":"Fu","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0040","article-title":"Interventions for emergency contraception","volume":"1","author":"Shen","year":"2019"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.06.056_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod. Pathol. Off. J. United States & Can. Acad. Patholo. Inc."},{"issue":"3","key":"10.1016\/j.ejogrb.2020.06.056_bib0050","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum. Reprod. (Oxford, England)"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.06.056_bib0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int. J. gynecological pathol. Off. J. Int. Soc. Gynecological Pathologists"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.06.056_bib0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2020.06.056_bib0065","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1933719117746764","article-title":"Characterization of molecular changes in endometrium associated with chronic use of progesterone receptor modulators: ulipristal acetate versus mifepristone","volume":"25","author":"Kannan","year":"2018","journal-title":"Reprod. Sci. (Thousand Oaks, Calif)"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.06.056_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.contraception.2018.05.020","article-title":"Molecular characterization of PRM-associated endometrial changes, PAEC, following mifepristone treatment","volume":"98","author":"Berger","year":"2018","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.06.056_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jcph.998","article-title":"Effect of the novel selective progesterone receptor modulator vilaprisan on ovarian activity in healthy women","volume":"58","author":"Schutt","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.06.056_bib0080","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14728222.2016.1180368","article-title":"Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies","volume":"20","author":"Wagenfeld","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.06.056_bib0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.contraception.2014.08.006","article-title":"A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception","volume":"90","author":"Huang","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.06.056_bib0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.contraception.2008.08.003","article-title":"Cost effectiveness of contraceptives in the United States","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0095","first-page":"45","article-title":"Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS","volume":"1","author":"Bednarek","year":"2010","journal-title":"Int J Womens Health"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.06.056_bib0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2020.06.056_bib0105","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/humrep\/17.10.2588","article-title":"Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen","volume":"17","author":"Gemzell-Danielsson","year":"2002","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ejogrb.2020.06.056_bib0110","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/humrep\/15.9.1969","article-title":"Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel","volume":"15","author":"Cheng","year":"2000","journal-title":"Hum. Reprod. (Oxford, England)"},{"issue":"11","key":"10.1016\/j.ejogrb.2020.06.056_bib0115","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/humrep\/dey296","article-title":"Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial","volume":"33","author":"Papaikonomou","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0120","series-title":"Blaustein\u2019s Pathology of the Female Genital Tract.","author":"Kurman","year":"2019"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.06.056_bib0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.06.056_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/IJWH.S33125","article-title":"Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial","volume":"5","author":"Carbonell","year":"2013","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.06.056_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humrep\/deg022","article-title":"Effect of long-term treatment with low-dose mifepristone on the endometrium","volume":"18","author":"Baird","year":"2003","journal-title":"Hum. Reprod. (Oxford, England)"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.06.056_bib0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2015.12.015","article-title":"A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate","volume":"93","author":"Jesam","year":"2016","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.06.056_bib0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.06.056_bib0150","article-title":"Progestagens and anti-progestagens for pain associated with endometriosis","author":"Prentice","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520304310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520304310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:57:34Z","timestamp":1778741854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520304310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0301211520304310"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.06.056","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.06.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}